
    
      Newly diagnosed non-Hodgkin lymphoma (NHL) patients will be recruited from each center
      participating in the LEO cohort. At time of consent, participants will be asked to completed
      several questionnaires collecting health history, current medical and quality of life
      questions. Patients will also provide a baseline blood sample that will processed locally and
      stored centrally for future research use. Additionally, consent is given for use of excess
      clinical tumor tissue for research use.
    
  